These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 7793084)
1. Characterization of putative defective interfering (DI) A/WSN RNAs isolated from the lungs of mice protected from an otherwise lethal respiratory infection with influenza virus A/WSN (H1N1): a subset of the inoculum DI RNAs. Noble S; Dimmock NJ Virology; 1995 Jun; 210(1):9-19. PubMed ID: 7793084 [TBL] [Abstract][Full Text] [Related]
2. Heterologous protection of mice from a lethal human H1N1 influenza A virus infection by H3N8 equine defective interfering virus: comparison of defective RNA sequences isolated from the DI inoculum and mouse lung. Duhaut SD; Dimmock NJ Virology; 1998 Sep; 248(2):241-53. PubMed ID: 9721233 [TBL] [Abstract][Full Text] [Related]
3. Approximately 150 nucleotides from the 5' end of an influenza A segment 1 defective virion RNA are needed for genome stability during passage of defective virus in infected cells. Duhaut S; Dimmock NJ Virology; 2000 Sep; 275(2):278-85. PubMed ID: 10998328 [TBL] [Abstract][Full Text] [Related]
4. Defective RNAs inhibit the assembly of influenza virus genome segments in a segment-specific manner. Duhaut SD; McCauley JW Virology; 1996 Feb; 216(2):326-37. PubMed ID: 8607262 [TBL] [Abstract][Full Text] [Related]
5. De novo generation and accumulation of tomato bushy stunt virus defective interfering RNAs without serial host passage. Law MD; Morris TJ Virology; 1994 Jan; 198(1):377-80. PubMed ID: 8259674 [TBL] [Abstract][Full Text] [Related]
6. Characterization of Toscana virus-defective interfering particles generated in vivo. Marchi A; Nicoletti L; Accardi L; Di Bonito P; Giorgi C Virology; 1998 Jun; 246(1):125-33. PubMed ID: 9657000 [TBL] [Abstract][Full Text] [Related]
7. Nonconserved nucleotides at the 3' and 5' ends of an influenza A virus RNA play an important role in viral RNA replication. Zheng H; Palese P; GarcĂa-Sastre A Virology; 1996 Mar; 217(1):242-51. PubMed ID: 8599209 [TBL] [Abstract][Full Text] [Related]
8. Genome nucleotide lengths that are divisible by six are not essential but enhance replication of defective interfering RNAs of the paramyxovirus simian virus 5. Murphy SK; Parks GD Virology; 1997 May; 232(1):145-57. PubMed ID: 9185598 [TBL] [Abstract][Full Text] [Related]
9. Protection of mice from lethal influenza: evidence that defective interfering virus modulates the immune response and not virus multiplication. Dimmock NJ; Beck S; McLain L J Gen Virol; 1986 May; 67 ( Pt 5)():839-50. PubMed ID: 2422317 [TBL] [Abstract][Full Text] [Related]
10. RNA interference of avian influenza virus H5N1 by inhibiting viral mRNA with siRNA expression plasmids. Zhou K; He H; Wu Y; Duan M J Biotechnol; 2008 Jun; 135(2):140-4. PubMed ID: 18456361 [TBL] [Abstract][Full Text] [Related]
12. Defective influenza A virus generated entirely from plasmids: its RNA is expressed in infected mouse lung and modulates disease. Duhaut SD; Dimmock NJ J Virol Methods; 2003 Mar; 108(1):75-82. PubMed ID: 12565156 [TBL] [Abstract][Full Text] [Related]
13. Interfering vaccine (defective interfering influenza A virus) protects ferrets from influenza, and allows them to develop solid immunity to reinfection. Mann A; Marriott AC; Balasingam S; Lambkin R; Oxford JS; Dimmock NJ Vaccine; 2006 May; 24(20):4290-6. PubMed ID: 16621180 [TBL] [Abstract][Full Text] [Related]
14. The genomic sequence of defective interfering Semliki Forest virus (SFV) determines its ability to be replicated in mouse brain and to protect against a lethal SFV infection in vivo. Thomson M; White CL; Dimmock NJ Virology; 1998 Feb; 241(2):215-23. PubMed ID: 9499796 [TBL] [Abstract][Full Text] [Related]
15. Defective interfering type A equine influenza virus (H3N8) protects mice from morbidity and mortality caused by homologous and heterologous subtypes of influenza A virus. Noble S; Dimmock NJ J Gen Virol; 1994 Dec; 75 ( Pt 12)():3485-91. PubMed ID: 7996140 [TBL] [Abstract][Full Text] [Related]
16. Interfering vaccine: a novel antiviral that converts a potentially virulent infection into one that is subclinical and immunizing. Noble S; McLain L; Dimmock NJ Vaccine; 2004 Aug; 22(23-24):3018-25. PubMed ID: 15297051 [TBL] [Abstract][Full Text] [Related]
17. Molecular characterization of tomato spotted Wilt virus defective interfering RNAs and detection of truncated L proteins. Inoue-Nagata AK; Kormelink R; Sgro JY; Nagata T; Kitajima EW; Goldbach R; Peters D Virology; 1998 Sep; 248(2):342-56. PubMed ID: 9721243 [TBL] [Abstract][Full Text] [Related]
18. Protection of mice from lethal influenza by adoptive transfer of non-neutralizing haemagglutination-inhibiting IgG obtained from the lungs of infected animals treated with defective interfering virus. McLain L; Dimmock NJ J Gen Virol; 1989 Oct; 70 ( Pt 10)():2615-24. PubMed ID: 2794973 [TBL] [Abstract][Full Text] [Related]
19. Defective interfering RNAs of Japanese encephalitis virus found in mosquito cells and correlation with persistent infection. Tsai KN; Tsang SF; Huang CH; Chang RY Virus Res; 2007 Mar; 124(1-2):139-50. PubMed ID: 17134784 [TBL] [Abstract][Full Text] [Related]
20. De novo generation of defective interfering-like RNAs in broad bean mottle bromovirus. Pogany J; Romero J; Huang Q; Sgro JY; Shang H; Bujarski JJ Virology; 1995 Oct; 212(2):574-86. PubMed ID: 7571427 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]